Health & Medicine
- Health & Medicine
Cocaine trumps food for female rats
A study in rats finds that males prefer food over cocaine while females prefer the drug, a step toward better understanding of sex differences in addiction.
- Health & Medicine
Alcohol heart benefits show up even after bypass surgery
Having two to three drinks a day was associated with decreased heart problems in men during the three years after the operation, researchers from Italy report.
- Health & Medicine
Mom’s past drug abuse may alter brain chemistry of offspring
A new study in rats suggests that the lingering effects of adolescent opiate use may be passed on for two generations, even if the female is drug-free when she gets pregnant.
- Life
Rare mutations key to brain disorders
Many cases of mental retardation can be explained by genetic variants that arise in affected individuals.
- Health & Medicine
A new way for blind mice to see
A new type of prosthetic eye can analyze patterns of cell activity to reproduce images similar to those produced in normal vision.
- Health & Medicine
Fructose poses gout risks even in women
Soft drinks are an even more potent source of the fat-generating sugar than had been thought, new research shows.
- Health & Medicine
Laptops and infertility: It matters how you sit
Men who keep their legs together while using the computers generate more sperm-endangering scrotal heat than those who splay them, a study finds.
- Life
Soil search suggests broad roots for antibiotic resistance
Drug-defeating genes are everywhere, but don’t blame dirt-dwelling bacteria for resistance seen in the clinic.
-
- Life
Genome may be mostly junk after all
A cross-species comparison suggests that more than 90 percent of the DNA in the human genome has no known function.
- Health & Medicine
Immune gene variants help stop HIV
Research on HIV-infected people who rarely develop AIDS might lead to better drugs or a vaccine.
- Tech
Election projections for science investments
The November 2, mid-term election results are in (mostly) and pundits are billing it as a historic turnabout. With a divided Congress, passing legislation — never an easy task — risks becoming harder still. And with fiscal austerity having been a leading campaign issue for the newbies, R&D is unlikely to see a major boost in federal funding during the next two years.
